Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL125129 | 0.98 | CYP3A4 (0.52) | CYP3A4MAPTKDM4EIDO1THRB | |
| Water SCHEMBL13583453 | 0.95 | CYP3A4 (0.56) | CYP3A4MAPTKDM4EIDO1THRB | |
| Hydrochloric Acid SCHEMBL538794 | 0.95 | CYP3A4 (0.56) | CYP3A4MAPTKDM4EIDO1THRB | |
| Bromide SCHEMBL11038149 | 0.95 | CYP3A4 (0.50) | CYP3A4MAPTKDM4EIDO1THRB | |
| SCHEMBL5839383 | 0.85 | LTA4H (0.46) | CYP3A4MAPTKDM4ELTA4HLMNA | |
| SCHEMBL13958950 | 0.85 | RAB9A (0.59) | MAPTIDO1MEN1KMT2ALTA4H | |
| SCHEMBL13958852 | 0.81 | BCHE (0.69) | MAPTMEN1KMT2ALMNAATM | |
| SCHEMBL14145021 | 0.81 | CYP3A4 (0.50) | CYP3A4MAPTKDM4EIDO1THRB | |
| SCHEMBL14433569 | 0.81 | PRMT6 (0.42) | CYP3A4MAPTKDM4EKMT2ALTA4H | |
| SCHEMBL11811445 | 0.80 | ATM (0.51) | CYP3A4MAPTKDM4EIDO1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122069876-A | Double-passivation flexible perovskite solar cell and preparation method thereof | 合肥工业大学 | 2026-05-19 | — | — | CN | claimed |
| CN-114583059-B | Perovskite solar cell with bias electrode | 华碧光能科技(苏州)有限公司 | 2024-02-13 | — | — | CN | claimed |
| CN-114583059-A | Perovskite solar cell with bias electrode | 华碧新能源技术研究(苏州)有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-122069876-A | Double-passivation flexible perovskite solar cell and preparation method thereof | 合肥工业大学 | 2026-05-19 | — | — | CN | disclosed |
| CN-122069876-A | Double-passivation flexible perovskite solar cell and preparation method thereof | 合肥工业大学 | 2026-05-19 | — | — | CN | disclosed |
| CN-114583059-B | Perovskite solar cell with bias electrode | 华碧光能科技(苏州)有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-114759142-A | Four-terminal laminated perovskite solar cell | 华碧新能源技术研究(苏州)有限公司 | 2022-07-15 | — | — | CN | disclosed |
| CN-114744119-A | Two-end laminated perovskite solar cell | 华碧新能源技术研究(苏州)有限公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-114583059-A | Perovskite solar cell with bias electrode | 华碧新能源技术研究(苏州)有限公司 | 2022-06-03 | — | — | CN | disclosed |
| US-20080171756-A1 | N-Substituted Glycine Derivatives: Prolyl Hydroxylase Inhibitors | SMITHKLINE BEECHAM CORPORATION | 2008-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080171756-A1 | N-Substituted Glycine Derivatives: Prolyl Hydroxylase Inhibitors | HIF1AN, EGLN2, EGLN3 | CYP3A4 1362/4885MAPT 4781/4885KDM4E 746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.